BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12398889)

  • 1. Telomerase: a target for cancer therapeutics.
    Shay JW; Wright WE
    Cancer Cell; 2002 Oct; 2(4):257-65. PubMed ID: 12398889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase inhibitors.
    White LK; Wright WE; Shay JW
    Trends Biotechnol; 2001 Mar; 19(3):114-20. PubMed ID: 11179805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Telomeres and telomerase as targeted therapies in cancer treatment].
    Souiden Y; Bouraoui A; Chaieb K; Mahdouani K
    Bull Cancer; 2010 Sep; 97(9):1087-104. PubMed ID: 20663741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase: a therapeutic target for the third millennium?
    Lavelle F; Riou JF; Laoui A; Mailliet P
    Crit Rev Oncol Hematol; 2000 May; 34(2):111-26. PubMed ID: 10799836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase inhibitors.
    Rowley PT; Tabler M
    Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere and telomerase in oncology.
    Mu J; Wei LX
    Cell Res; 2002 Mar; 12(1):1-7. PubMed ID: 11942406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting human telomerase by antisense oligonucleotides and ribozymes.
    Folini M; Pennati M; Zaffaroni N
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer.
    Sekhri K
    J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase inhibition in cancer therapeutics: molecular-based approaches.
    Cunningham AP; Love WK; Zhang RW; Andrews LG; Tollefsbol TO
    Curr Med Chem; 2006; 13(24):2875-88. PubMed ID: 17073634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells.
    Herbert BS; Wright AC; Passons CM; Wright WE; Ali IU; Kopelovich L; Shay JW
    J Natl Cancer Inst; 2001 Jan; 93(1):39-45. PubMed ID: 11136840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting telomerase for cancer therapeutics.
    Shay JW; Keith WN
    Br J Cancer; 2008 Feb; 98(4):677-83. PubMed ID: 18231105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere maintenance mechanisms as a target for drug development.
    Bearss DJ; Hurley LH; Von Hoff DD
    Oncogene; 2000 Dec; 19(56):6632-41. PubMed ID: 11426649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase as a therapeutic target. Therapeutic potential of telomerase inhibitors.
    Double JA
    Methods Mol Biol; 2002; 191():209-16. PubMed ID: 11951608
    [No Abstract]   [Full Text] [Related]  

  • 20. Telomere maintenance as a target for drug discovery.
    Sekaran V; Soares J; Jarstfer MB
    J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.